Marchaim D, Zaidenstein R, Lazarovitch T, Karpuch Y, Ziv T, Weinberger M
Infectious Diseases Unit, Assaf Harofeh Medical Center, Zerifin 70300, Israel.
Eur J Clin Microbiol Infect Dis. 2008 Nov;27(11):1045-51. doi: 10.1007/s10096-008-0545-z. Epub 2008 Jun 5.
Increased resistance among isolates causing bacteremia constitutes a major challenge to medical practitioners and institutions. Variability between institutes is substantial, and requires the individual analysis of local trends. An eight-year (1997-2004) surveillance study of episodes of bacteremia was conducted in an 850-bed university hospital in central Israel. Trends of incidence, resistance, age, and mortality were analyzed. We studied 6,096 patient-unique episodes of bacteremia, of which, 2,722 (45.3%) were nosocomial and 523 (9.2%) involved children less than 18 years of age. The overall incidence of bacteremia episodes has increased over the study years by 39% and the patient mean age by 7.5 years. Gram-negative organisms accounted for 72% of hospital-acquired cases and 69% of community-acquired cases. There was a substantial increase in the incidence of nosocomial episodes, predominantly due to Gram-negative isolates, mainly Acinetobacter baumannii, Klebsiella pneumoniae, and Escherichia coli. Increased resistance to broad-spectrum antibiotics was noted among Gram-negative organisms, including quinolones (in K. pneumoniae), imipenem (A. baumannii and P. aeruginosa), piperacillin-tazobactam (K. pneumoniae), and amikacin (A. baumannii and P. aeruginosa). Increased resistance to oxacillin among coagulase-negative staphylococci was also noted. The all-cause mortality rates showed a significant rise. The patient age, intensive care unit (ICU) stay, and hospital acquisition were independently associated with mortality. We describe an increase in the incidence and resistance of Gram-negative organisms causing bacteremia and concomitant ageing of the patients with bacteremia. Similar patterns have been reported from other localities, and are of real concern.
引起菌血症的分离株耐药性增加,这对医生和医疗机构构成了重大挑战。不同机构之间的差异很大,需要对当地趋势进行单独分析。在以色列中部一家拥有850张床位的大学医院,开展了一项为期八年(1997 - 2004年)的菌血症发作监测研究。分析了发病率、耐药性、年龄和死亡率的趋势。我们研究了6096例患者特异性菌血症发作,其中2722例(45.3%)为医院获得性菌血症,523例(9.2%)涉及18岁以下儿童。在研究期间,菌血症发作的总体发病率增加了39%,患者平均年龄增加了7.5岁。革兰氏阴性菌占医院获得性病例的72%,社区获得性病例的69%。医院获得性菌血症发作的发病率大幅增加,主要是由于革兰氏阴性分离株,主要是鲍曼不动杆菌、肺炎克雷伯菌和大肠杆菌。革兰氏阴性菌对广谱抗生素的耐药性增加,包括喹诺酮类(肺炎克雷伯菌)、亚胺培南(鲍曼不动杆菌和铜绿假单胞菌)、哌拉西林 - 他唑巴坦(肺炎克雷伯菌)和阿米卡星(鲍曼不动杆菌和铜绿假单胞菌)。凝固酶阴性葡萄球菌对苯唑西林的耐药性也有所增加。全因死亡率显著上升。患者年龄、重症监护病房(ICU)住院时间和医院获得性感染与死亡率独立相关。我们描述了引起菌血症的革兰氏阴性菌的发病率和耐药性增加,以及菌血症患者的年龄增长。其他地区也报告了类似的模式,令人深感担忧。